1 |
Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun 2020;11:4059.
DOI
|
2 |
1 vs. 3,055: Koreans' rate of Covid-19 antibodies. Seoul: Korea Biomedical Review, 2020. Accessed 2020 Sep 19. Available from: https://www.koreabiomed.com/news/articleView.html?idxno=8732.
|
3 |
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-413.
DOI
|
4 |
Agresti A. An Introduction to Categorical Data Analysis. Hoboken: John Wiley & Sons, 2018. pp. 11-16.
|
5 |
Coronavirus (COVID-19): antibody testing. London: Department of Health and Social Care, 2020. Accessed 2020 Sep 19. Available from: https://www.gov.uk/government/publications/ coronavirus-covid-19-antibody-tests/coronavirus-covid-19-antibody-tests.
|
6 |
Daily number of new reported cases of COVID-19 by country worldwide. Solna: European Centre for Disease Prevention and Control, 2020. Accessed 2020 Sep 19. Available from: https://opendata.ecdc.europe.eu/covid19/casedistribution/csv.
|
7 |
Antibody test to check if you've had coronavirus. London: NHS, 2020. Accessed 2020 Sep 19. Available from: https://www.nhs.uk/conditions/coronavirus-covid-19/testing-and-tracing/antibody-test-to-check-if-youve-had-coronavirus/.
|
8 |
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-1207.
DOI
|
9 |
Spanish antibody study shows 5% of population exposed to coronavirus. New York: Reuters, 2020. Accessed 2020 Sep 19. Available from: https://www.reuters.com/article/us-health-coronavirus-spain-study-idUSKBN2471AL.
|
10 |
Dobson AJ, Barnett AG. An Introduction to Generalized Linear Models. Boca Raton: CRC Press, 2018. pp. 229-238.
|
11 |
Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 2020;58:e00512-20.
|
12 |
Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020;20:269-270.
DOI
|
13 |
WHO director-general's opening remarks. Geneva: World Health Organization, 2020. Accessed 2020 Sep 19. Available from: https://www.who.int/dg/speeches/detail/who-director-generals-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
|
14 |
Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis 2020 Apr 19 [Epub]. https://doi.org/10.1093/cid/ciaa461.
DOI
|
15 |
Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005;24:44-46.
DOI
|
16 |
Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;20:398-400.
DOI
|
17 |
Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007;357:1450-1451.
DOI
|
18 |
Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011;52:447-456.
DOI
|
19 |
S. Korea begins coronavirus antibody tests. Seoul: Yonhap News Agency, 2020. Accessed 2020 Sep 19. Available from: https://en.yna.co.kr/view/AEN20200630007300320.
|
20 |
Agresti A. Categorical Data Analysis. 3rd ed. Hoboken: John Wiley& Sons, 2013. pp. 12-16.
|
21 |
Antibody (serology) testing for COVID-19: information for patients and consumers. Silver Spring: Food and Drug Administration, 2020. Accessed 2020 Sep 19. Available from: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/antibody-serology-testing-covid-19-information-patients-and-consumers.
|
22 |
Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003;9:309.
|
23 |
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-1242.
DOI
|
24 |
Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020;14:69-71.
DOI
|
25 |
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 2020;323:1582-1589.
DOI
|
26 |
Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020;26:845-848.
DOI
|